These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1185 related items for PubMed ID: 21092551

  • 1. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
    Wang Y, Li LZ, Ye L, Niu XL, Liu X, Zhu YQ, Sun WJ, Liang YJ.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):691-8. PubMed ID: 21092551
    [Abstract] [Full Text] [Related]

  • 2. Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells.
    Wang Y, Niu XL, Qu Y, Wu J, Zhu YQ, Sun WJ, Li LZ.
    Cancer Lett; 2010 Sep 01; 295(1):110-23. PubMed ID: 20236757
    [Abstract] [Full Text] [Related]

  • 3. Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells.
    Wang Y, Qu Y, Niu XL, Sun WJ, Zhang XL, Li LZ.
    Cytokine; 2011 Nov 01; 56(2):365-75. PubMed ID: 21742513
    [Abstract] [Full Text] [Related]

  • 4. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis.
    Liu JR, Fletcher B, Page C, Hu C, Nunez G, Baker V.
    Gynecol Oncol; 1998 Sep 01; 70(3):398-403. PubMed ID: 9790794
    [Abstract] [Full Text] [Related]

  • 5. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
    Asselin E, Mills GB, Tsang BK.
    Cancer Res; 2001 Mar 01; 61(5):1862-8. PubMed ID: 11280739
    [Abstract] [Full Text] [Related]

  • 6. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel.
    Mitsuuchi Y, Johnson SW, Selvakumaran M, Williams SJ, Hamilton TC, Testa JR.
    Cancer Res; 2000 Oct 01; 60(19):5390-4. PubMed ID: 11034077
    [Abstract] [Full Text] [Related]

  • 7. Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells.
    Villedieu M, Louis MH, Dutoit S, Brotin E, Lincet H, Duigou F, Staedel C, Gauduchon P, Poulain L.
    Gynecol Oncol; 2007 Apr 01; 105(1):31-44. PubMed ID: 17275076
    [Abstract] [Full Text] [Related]

  • 8. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].
    Li M, Yu LL, Cai LQ, Wang HB, Wang ZH, Wang ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb 01; 41(2):121-5. PubMed ID: 16640863
    [Abstract] [Full Text] [Related]

  • 9. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
    Li Z, Hu S, Wang J, Cai J, Xiao L, Yu L, Wang Z.
    Gynecol Oncol; 2010 Oct 01; 119(1):125-30. PubMed ID: 20624637
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
    Hayakawa J, Ohmichi M, Kurachi H, Kanda Y, Hisamoto K, Nishio Y, Adachi K, Tasaka K, Kanzaki T, Murata Y.
    Cancer Res; 2000 Nov 01; 60(21):5988-94. PubMed ID: 11085518
    [Abstract] [Full Text] [Related]

  • 11. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
    Pan L, Tong Y, Jin Y, Zhou S, Zhang Y, Yang X, Mao N.
    Chin Med J (Engl); 2001 Sep 01; 114(9):929-32. PubMed ID: 11780384
    [Abstract] [Full Text] [Related]

  • 12. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y, Yang J, Gao Y, Zhao XL, Li HZ, Yao Z.
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul 01; 44(7):522-8. PubMed ID: 19957553
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S, Jiao JW, Sun KX, Zong ZH, Zhao Y.
    Drug Des Devel Ther; 2015 Jul 01; 9():5225-35. PubMed ID: 26396496
    [Abstract] [Full Text] [Related]

  • 14. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
    Liu HZ, Yu C, Yang Z, He JL, Chen WJ, Yin J, Li WM, Liu HT, Wang YX.
    Mol Med Rep; 2011 Jul 01; 4(5):985-92. PubMed ID: 21687949
    [Abstract] [Full Text] [Related]

  • 15. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
    Ma JJ, Chen BL, Xin XY.
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct 01; 146(2):222-6. PubMed ID: 19758744
    [Abstract] [Full Text] [Related]

  • 16. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS, Hua J, Gibb RK, Mutch DG, Herzog TJ.
    Gynecol Oncol; 2004 Jul 01; 94(1):67-73. PubMed ID: 15262121
    [Abstract] [Full Text] [Related]

  • 17. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM, Turchi JJ.
    Cancer Res; 1999 Jul 01; 59(13):3077-83. PubMed ID: 10397248
    [Abstract] [Full Text] [Related]

  • 18. Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells.
    Yang X, Xing H, Gao Q, Chen G, Lu Y, Wang S, Ma D.
    Gynecol Oncol; 2005 May 01; 97(2):413-21. PubMed ID: 15863139
    [Abstract] [Full Text] [Related]

  • 19. Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway.
    Yang YI, Lee KT, Park HJ, Kim TJ, Choi YS, Shih IeM, Choi JH.
    Carcinogenesis; 2012 Dec 01; 33(12):2488-98. PubMed ID: 23027625
    [Abstract] [Full Text] [Related]

  • 20. Akt involvement in paclitaxel chemoresistance of human ovarian cancer cells.
    Kim SH, Juhnn YS, Song YS.
    Ann N Y Acad Sci; 2007 Jan 01; 1095():82-9. PubMed ID: 17404021
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 60.